2012 US medicine sales show shifts by drug type

U.S. sales levels for many widely used drug categories shifted significantly in 2012, with sales in some classes declining sharply due to an infusion of cheaper new generic pills. Other categories grew, mainly with the introduction of new, generally expensive medicines Continue reading

Medical School Pathology, 2013 Season, Session #10: Immune Disorders II – Video




Medical School Pathology, 2013 Season, Session #10: Immune Disorders II Medical School Pathology, 2013 Season, Session #10: Immune Disorders II This is session #10 of 63 sessions of a medical school pathology course taught online… By: WashingtonDeceit Continue reading

Research examines stress, space flight impact on body’s ability to fight viruses

Fighting viruses is a regular battle for your body, one it routinely wins if it has a healthy immune system. But compromised systems, as experienced occasionally by astronauts during space flights, can allow viruses to return Continue reading

Tailored gene therapy approach could replace drug treatments for HIV patients

One of the biggest problems in treating HIV patients is the amount of daily individual medications it takes to keep the virus at bay. In a new study, scientists at the Stanford University School of Medicine have engineered a new approach to tailored gene therapy that they say makes key cells of the immune system resistant to attack from the HIV virus, which may eventually lead to the removal of life-long dependencies on drugs for patients living with HIV. The drug treatment regime for HIV is intended to block the reception of the virus at different stages of the replication process Continue reading

LAUGHTER IS YOUR BIRTHRIGHT – Video




LAUGHTER IS YOUR BIRTHRIGHT Laughter is your birthright, a natural part of life that is innate and inborn. Infants begin smiling during the first weeks of life and laugh out loud within months of being born. Continue reading

Nanotechnology to Treat Multiple Sclerosis and More

Category: Science & Technology Posted: November 20, 2012 07:51AM Author: Guest_Jim_* Sometimes our greatest ally is also our worst enemy. The immune system which protects us from foreign bacteria as well as internal mutations can turn on our bodies by attacking healthy cells. This behavior leads to different kinds of diseases including multiple sclerosis (MS), Type 1 diabetes, asthma, and some allegories. Continue reading

How nanotechnology can improve health

WELLINGTON, Fla. – Each day, it becomes tougher for Howard Chiet to get around his Wellington home. “I progressed from a cane to a walker, from a walker to a wheelchair,” he said. Continue reading

Space station and space flight gravity influence immune system development

ScienceDaily (Oct. 15, 2012) New research findings recently published in The FASEB Journal, show that immune system development is affected by gravity changes, as reported by researchers from the University of Lorraine and University of Luxembourg. Astronauts are exposed to stresses, during launch and landing, which disrupts their body’s natural defenses against infection. Continue reading

Johns Hopkins researchers develop gene-based therapy against myasthenia gravis

Working with mice, Johns Hopkins researchers say they have developed a gene-based therapy to stop the rodent equivalent of the autoimmune disease myasthenia gravis by specifically targeting the destructive immune response the disorder triggers in the body. The technique, the result of more than 10 years of work, holds promise for a highly specific therapy for the progressively debilitating muscle-weakening human disorder, one that avoids the need for long-term, systemic immunosuppressant drugs that control the disease but may create unwanted side effects. The research, if replicated in humans, could be a big leap in treating not only myasthenia gravis, but also other autoimmune disorders, the researchers say. Continue reading

Power of the Dream Ventures Acquires Genetic Immunity

BUDAPEST, HUNGARY–(Marketwire – Sep 28, 2012) – Power of the Dream Ventures, Inc. ( OTCBB : PWRV ) is pleased to announce the acquisition of Genetic Immunity, Inc., a Phase III clinical stage biotechnology company with experimental nanomedicines that will lead to the next generation of immunotherapies, in a market that is projected to reach $11.00 billion by 2018. Genetic Immunity’s lead product candidate is an immune boosting drug for HIV, which is now only treated by antiretroviral drugs that decrease the ability of the immune system to fight with the virus. Continue reading

'Bubble babies' immune systems restored

LOS ANGELES UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called “bubble boy” disease, a life-threatening condition that if left untreated can be fatal within one to two years. Continue reading

Researchers improve gene therapy technique for children with immune disorder

Public release date: 11-Sep-2012 [ | E-mail | Share ] Contact: Claire Gwayi-Chore cgwayi-chore@hematology.org 202-776-0544 American Society of Hematology By including chemotherapy as a conditioning regimen prior to treatment, researchers have developed a refined gene therapy approach that safely and effectively restores the immune system of children with a form of severe combined immunodeficiency (SCID), according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH). Continue reading